P/Q-type calcium channel antibodies, Lambert–Eaton myasthenic syndrome and survival in small cell lung cancer
- 31 July 2005
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 164 (1-2), 161-165
- https://doi.org/10.1016/j.jneuroim.2005.04.001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hu and Voltage-Gated Calcium Channel (VGCC) Antibodies Related to the Prognosis of Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancerNeurology, 2002
- The action of Lambert–Eaton myasthenic syndrome immunoglobulin G on cloned human voltage‐gated calcium channelsMuscle & Nerve, 2002
- Prognostic factors for patients with small cell lung carcinomaCancer, 2000
- Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinomaThe Lancet, 1999
- Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndromeBrain, 1997
- Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndromeJournal of the Neurological Sciences, 1997
- Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic SyndromesNew England Journal of Medicine, 1995
- Detection of the anti‐Hu antibody in the serum of patients with small cell lung cancer—A quantitative western blot analysisAnnals of Neurology, 1990
- THE LAMBERT-EATON MYASTHENIC SYNDROMEBrain, 1988